Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment

被引:136
作者
Evans, DR
Parikh, VV
Khan, MM
Coussons, C
Buckley, PF
Mahadik, SP
机构
[1] Vet Affairs Med Ctr, Med Res Serv 242, Med Res & Mental Hlth Serv Lines, Augusta, GA 30904 USA
[2] Med Coll Georgia, Dept Psychiat & Hlth Behav, Augusta, GA 30912 USA
来源
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 2003年 / 69卷 / 06期
关键词
schizophrenia; membrane phospholipids; antipsychotics; essential fatty acids;
D O I
10.1016/j.plefa.2003.08.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A role of indices of oxidative stress, oxidative injury, and abnormal membrane phospholipid, specifically the phospholipid essential polyunsaturated fatty acids (EPUFAs) metabolism has been suggested based on studies in separate groups of patients with or without medication. The current study investigated the relationship between these biochemical measures in first-episode psychotic patients (N = 16) at baseline and after 6 months of antipsychotic treatment (N = 5 each with risperidone and olanzapine) and compared them to matched normal subjects. The indices of oxidative stress included: antioxidant enzymes; superoxide dismutase, glutathione peroxidase and catalase; and the oxidative injury as the levels of plasma lipid peroxides. The key membrane EPUFA's been; linolenic acid, arachidonic acid, nervonic acid, docosapentaenoic acid and docosahexaenoic acid. Furthermore, the changes in these biochemical measures were correlated with clinical symptomatology. Data indicated that, at baseline, reduced levels of antioxidant enzymes were associated with increased plasma lipid peroxides and reduced membrane EPUFAs, particularly omega-3 fatty acids. Furthermore, these biochemical measures normalized after 6 months of antipsychotic treatment. Parallel-improved psychopathology indicated that membrane EPUFA status might be partly affected by oxidative damage, which together may contribute to the pathophysiology and thereby, psychopathology of schizophrenia. These data also support the augmentation of antipsychotic treatment by supplementation with a combination of antioxidants and omega-3 fatty acids. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:393 / 399
页数:7
相关论文
共 38 条
[1]   Supplementation with a combination of ω-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia [J].
Arvindakshan, M ;
Ghate, M ;
Ranjekar, PK ;
Evans, DR ;
Mahadik, SP .
SCHIZOPHRENIA RESEARCH, 2003, 62 (03) :195-204
[2]   Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients [J].
Arvindakshan, M ;
Sitasawad, S ;
Debsikdar, V ;
Ghate, M ;
Evans, D ;
Horrobin, DF ;
Bennett, C ;
Ranjekar, PK ;
Mahadik, SP .
BIOLOGICAL PSYCHIATRY, 2003, 53 (01) :56-64
[3]  
ARVINDAKSHAN M, 2003, THESIS PUNE U PUNE
[4]   Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group [J].
Assies, J ;
Lieverse, R ;
Vreken, P ;
Wanders, RJA ;
Dingemans, PMJA ;
Linszen, DH .
BIOLOGICAL PSYCHIATRY, 2001, 49 (06) :510-522
[5]   FAT CONSUMPTION AND SCHIZOPHRENIA [J].
CHRISTENSEN, O ;
CHRISTENSEN, E .
ACTA PSYCHIATRICA SCANDINAVICA, 1988, 78 (05) :587-591
[6]   A RED-CELL MEMBRANE ABNORMALITY IN A SUBGROUP OF SCHIZOPHRENIC-PATIENTS - EVIDENCE FOR 2 DISEASES [J].
GLEN, AIM ;
GLEN, EMT ;
HORROBIN, DF ;
VADDADI, KS ;
SPELLMAN, M ;
MORSEFISHER, N ;
ELLIS, K ;
SKINNER, FS .
SCHIZOPHRENIA RESEARCH, 1994, 12 (01) :53-61
[7]   THE MEMBRANE HYPOTHESIS OF SCHIZOPHRENIA [J].
HORROBIN, DF ;
GLEN, AIM ;
VADDADI, K .
SCHIZOPHRENIA RESEARCH, 1994, 13 (03) :195-207
[8]   The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia [J].
Horrobin, DF .
SCHIZOPHRENIA RESEARCH, 1998, 30 (03) :193-208
[9]  
HORROBIN DF, 1999, PHOSPHOLIPID SPECTRU, P113
[10]   THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) FOR SCHIZOPHRENIA [J].
KAY, SR ;
FISZBEIN, A ;
OPLER, LA .
SCHIZOPHRENIA BULLETIN, 1987, 13 (02) :261-276